A Nevada court has temporarily blocked the prediction market platform Polymarket, siding with state regulators who argue its event contracts constitute illegal gambling. The ruling intensifies a global regulatory crackdown that threatens the core business model of an emerging financial sector.
Amidst global market volatility, a focused look at Asia reveals companies with resilient fundamentals trading at compelling valuations. We analyze three such names from the education, healthcare, and chemical sectors.
As Bitcoin tumbled below $80,000, a stark divergence emerged: options markets flashed warning signs while prediction contracts remained oddly calm, exposing a fundamental clash in how crypto markets price risk.
A recent wave of deadly attacks in Pakistan's Balochistan province, claimed by the banned Baloch Liberation Army (BLA), has spotlighted the escalating capabilities and ambitions of a group that threatens regional stability and critical Chinese investments.
A proposed wealth tax on California's ultra-rich has ignited a fierce debate, pitting tech billionaires against a coalition of millionaires who argue it's time for the wealthy to pay more. The fight echoes past battles over Silicon Valley's influence and raises questions about the state's economic future.
As regional markets adjust to easing geopolitical pressures, a closer look reveals resilient performers. We analyze three small-cap stocks—R.A.K. Ceramics, TALCO Industrial, and Emilia Development—that are navigating the current volatility with strong fundamentals and potential for growth.
The vital Rafah border crossing between Gaza and Egypt has partially reopened for a trial period, allowing a restricted number of Palestinian civilians to cross. This move implements a key provision of the U.S.-mediated ceasefire, though severe limitations and high costs cast doubt on its immediate humanitarian impact.
Israeli authorities have issued expulsion orders to a Bedouin community near Ramallah, while settler attacks on schools and homes intensify across the occupied West Bank, further constricting Palestinian living space.
President Trump's anticipated nomination of former Fed Governor Kevin Warsh, a vocal critic of the central bank's post-crisis asset purchases, is shifting market focus from interest rates to the future of the Fed's $6.6 trillion balance sheet and its fundamental role in financial markets.
As the ASX braces for a turbulent week amid rate hike fears, investors are scouring the market for resilient opportunities. We delve into three penny stocks—spanning energy, retail, and healthcare—that combine financial stability with distinct growth narratives for the discerning investor.
As Super Micro Computer (SMCI) prepares to release its quarterly results, the market watches to see if its AI server business can sustain explosive growth and justify its soaring valuation.
Oracle Corp. plans a colossal $45-$50 billion capital raise in 2026 to expand its cloud infrastructure, aiming to meet surging demand from AI giants like OpenAI and Nvidia. The move comes as the company's aggressive data center spending pushes its free cash flow negative, a condition projected to last for years.
Micron Technology, a key player in memory chips, is poised for explosive earnings growth fueled by insatiable AI demand. Yet, its cyclical nature and commoditized market pose significant long-term risks for investors.
As artificial intelligence drives an unprecedented surge in electricity demand, one utility company—Constellation Energy—is uniquely positioned with its vast nuclear fleet to meet the need, turning an industry-wide bottleneck into a significant growth opportunity.
Faced with the realities of modern warfare in Ukraine, NATO is fast-tracking innovation, creating an unprecedented opportunity for agile tech founders to access a once-closed defense market.
The iconic outdoor retailer Eddie Bauer is preparing to file for Chapter 11 bankruptcy, a move that will close its entire fleet of roughly 200 physical stores across the U.S. and Canada. While its e-commerce and wholesale operations will live on, the decision marks a dramatic retreat from the mall landscape it helped define for decades.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
QuantumScape's stock has plummeted 52% in three months, reigniting the debate over its valuation. While bulls point to a disruptive solid-state battery technology and a theoretical fair value of $55, skeptics highlight the absence of revenue and monumental scaling challenges. We examine the risks and rewards behind the volatility.
SanDisk Corporation's stock hit an all-time peak following a blockbuster earnings report for Q2 FY2026, fueled by surging demand for its storage solutions from the artificial intelligence sector.
Facing a significant stock decline and a challenging Medicare Advantage outlook, UnitedHealth Group announces leadership changes and a 'Back to Basics' operational reset, aiming to stabilize its core business amid shifting market dynamics.
